Skip to content

DMT research published in 2024

Page 2 of 3: studies 21 to 40 of 60, newest first. Back to the DMT overview

Studies

The anxiolytic-like effect of the alkaloid fraction of the psychedelic plant Mimosa tenuiflora (Willd.) Poir.

Natural Product Research September 18, 2024 Jady Vitoria Barjud Pereira Ferreira, Ana Marcia de Freitas Pessoa, Rita de Cassia de Lima Sousa et al. 1 citation

The present work investigated the anxiolytic effect of the alkaloid fraction (AF II) from the root bark of Mimosa tenuiflora. Female Swiss mice of 6 weeks old were used in this study. The animals were divided into three groups: 0.9% NaCl (vehicle group, s.c.), AF II (6 mg/kg, s.c.), and diazepam - DZP (5 mg/kg, s.c.). The light/dark box and elevated plus maze tests evaluated the animal anxiety....

Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.

Cellular and Molecular Life Sciences September 10, 2024 Klemens Egger, Helena Aicher, Paul Cumming et al. 30 citations

The potent hallucinogen N,N-dimethyltryptamine (DMT) has garnered significant interest in recent years due to its profound effects on consciousness and its therapeutic psychopotential. DMT is an integral (but not exclusive) psychoactive alkaloid in the Amazonian plant-based brew ayahuasca, in which admixture of several β-carboline monoamine oxidase A (MAO-A) inhibitors potentiate the activity...

Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.

Pharmacological Research September 1, 2024 Giorgia Caspani, Simon Ruffell, WaiFung Tsang et al. 13 citations

Psychedelics have emerged as promising therapeutics for several psychiatric disorders. Hypotheses around their mechanisms have revolved around their partial agonism at the serotonin 2 A receptor, leading to enhanced neuroplasticity and brain connectivity changes that underlie positive mindset shifts. However, these accounts fail to recognise that the gut microbiota, acting via the gut-brain...

DMT – psychodelik otwierający duszę

Kosmos August 8, 2024 Izabela Szpręgiel

Dimethyltryptamine (DMT), which is a psychedelic substance, has been a target of neuropharmacological research for years, mainly because of its potential use in the treatment of psychiatric disorders. The pineal gland is the best studied organ for endogenous DMT synthesis. At the same time, the role of DMT has not been clearly established. The association of the pineal gland with endogenous DMT...

Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine benzoate) in healthy participants.

Journal of Psychopharmacology August 1, 2024 James Jonathan Rucker, Claire T. Roberts, Mathieu Seynaeve et al. 32 citations

To investigate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BPL-003, a novel intranasal benzoate salt formulation of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), in healthy participants. In all, 44 psychedelic-naïve participants enrolled in the double-blind, placebo-controlled single ascending dose study (1-12 mg BPL-003). Concentrations of 5-MeO-DMT and its...

Novel extended-release transdermal formulations of the psychedelic N,N-dimethyltryptamine (DMT).

European Journal of Pharmaceutical Sciences August 1, 2024 Christopher G Witowski, Mika R Hess, Nate T Jones et al. 7 citations

There is considerable evidence from the literature that psychedelics, such as N,N-dimethyltryptamine (DMT), are safe and effective treatments for depression. However, clinical administration to induce psychedelic effects and expensive psychotherapy-assisted treatments likely limit accessibility to the average patient. There is emerging evidence that DMT promotes positive behavioral changes in...

Novel Thermosensitive and Mucoadhesive Nasal Hydrogel Containing 5-MeO-DMT Optimized Using Box-Behnken Experimental Design.

Polymers July 29, 2024 Pablo Miranda, Analía Castro, Paola Díaz et al. 5 citations

We present the development and characterization of a nasal drug delivery system comprised of a thermosensitive mucoadhesive hydrogel based on a mixture of the polymers Poloxamer 407, Poloxamer 188 and Hydroxypropyl-methylcellulose, and the psychedelic drug 5-methoxy-N,-N-dimethyltryptamine. The development relied on a 3 × 3 Box-Behnken experimental design, focusing on optimizing gelification...

DOI: 10.3390/polym16152148 (opens in new tab) Full text (opens in new tab) Drug delivery systems Nasal drug administration Thermosensitive polymers Pharmaceutical formulations +7

Author Correction: 5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats

Scientific Reports July 14, 2024 Annie C. Souza, Bryan C. Souza, Arthur França et al. 1 citation

The original version of this Article contained an error in Affiliation 6, which was incorrectly given as ‘Brain Network Dynamics Unit, University of Oxford, Oxford, UK.’ The correct affiliation is listed below:

Unlocking the Therapeutic Potential of DMT’s: Molecular Modelling Insights into Nueropharmacological Mechanisms and Clinical Prospects

Letters in Applied NanoBioScience June 30, 2024 Rishabh Khare, K. Rajagopal, Srikanth Jupudi et al.

Depression is a critical mental ailment as it impacts about 5% of the global population, prompting scientists to create more efficacious antidepressants. The monoamine-deficiency hypothesis suggests that depression is caused by the depletion of certain neurotransmitters like serotonin, norepinephrine, and dopamine in the brain, where serotonin plays the most critical role among all and has been...

5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood—a retrospective case study

June 7, 2024 Mika Turkia 1 citation preprint

5-MeO-DMT is a psychedelic substance with a short duration of action and intensive effects. Its therapeutic efficacy and practicality may significantly surpass those of classical psychedelics such as ayahuasca and LSD. This retrospective ethnographic inquiry features a woman in her mid-thirties who witnessed her mother's violent suicide and its bloody aftermath at the age of three. Before and...

DOI: 10.31234/osf.io/bvk2f (opens in new tab) Sexual abuse Compassion Neglect Facilitator +2

Ayahuasca: N, N-dimetiltriptamina (DMT) una Herramienta Psicodélica con Posibles Propiedades Psicoplastogénicas

Revista de Investigación Científica y Tecnológica June 2, 2024

Ayahuasca, un té utilizado inicialmente por pueblos amerindios, con fines medicinales, religiosos y sacramentales, y luego se difundió en muchas partes del mundo en contextos urbanos, que, además de su uso religioso y espiritual, también el uso recreativo. El té de ayahuasca contiene un perfil químico bien característico de compuestos alcaloides psicoactivos que son N, N-dimetiltriptamina (DMT)...

The Role of Ayahuasca in Colorectal Adenocarcinoma Cell Survival, Proliferation and Oxidative Stress.

Pharmaceuticals June 2, 2024 Joana Gonçalves, Mariana Feijó, Sílvia Socorro et al.

The psychedelic beverage ayahuasca is originally obtained by Banisteriopsis caapi (B. caapi) (BC) and Psychotria viridis (P. viridis) (PV). However, sometimes these plant species are replaced by others that mimic the original effects, such as Mimosa hostilis (M. hostilis) (MH) and Peganum harmala (P. harmala) (PH). Its worldwide consumption and the number of studies on its potential therapeutic...

Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT

bioRxiv (Cold Spring Harbor Laboratory) May 31, 2024 Jakub Vohryzek, Selen Atasoy, Gustavo Deco et al. 8 citations preprint

Exploring the intricate relationship between brain's structure and function, and how this affects subjective experience is a fundamental pursuit in neuroscience. Psychedelic substances offer a unique insight into the influences of specific neurotransmitter systems on perception, cognition and consciousness. Specifically, their impact on brain function propagates across the structural...

DOI: 10.1101/2024.05.30.596410 (opens in new tab) Full text (opens in new tab) Connectome Consciousness Harmonics Perception +2

5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats.

Scientific Reports May 17, 2024 Annie C. Souza, Bryan C. Souza, Arthur França et al. 7 citations

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a potent classical psychedelic known to induce changes in locomotion, behaviour, and sleep in rodents. However, there is limited knowledge regarding its acute neurophysiological effects. Local field potentials (LFPs) are commonly used as a proxy for neural activity, but previous studies investigating psychedelics have been hindered by confounding...

DOI: 10.1038/s41598-024-61474-9 (opens in new tab) Full text (opens in new tab) 5-MEO-DMT Hippocampal oscillations Prefrontal cortex Psychedelics hallucinogens +5

Effect of Intravenous Delivery of N,N Dimethyltryptamine on Sleep-Wake States in Rat

Physiology May 1, 2024 Rachel Summerfield, Trent Groenhout, Tiecheng Liu et al.

Psychedelics, including N, N, Dimethyltryptamine (DMT), are being increasingly explored for therapeutic potential to treat psychiatric disorders such as depression, anxiety, and post-traumatic stress disorder. These and other psychiatric conditions have a bidirectional relationship with sleep patterns but the impact of psychedelics, particularly DMT, on sleep architecture is incompletely...

N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer's disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk.

Alzheimer's Research & Therapy May 1, 2024 Dan Cheng, Zhuo-Gui Lei, Kin Chu et al. 41 citations

Aberrant neuronal Sigma-1 receptor (Sig-1r)-mediated endoplasmic reticulum (ER)- mitochondria signaling plays a key role in the neuronal cytopathology of Alzheimer's disease (AD). The natural psychedelic N, N-dimethyltryptamine (DMT) is a Sig-1r agonist that may have the anti-AD potential through protecting neuronal ER-mitochondrial interplay. 3×TG-AD transgenic mice were administered with...

DOI: 10.1186/s13195-024-01462-3 (opens in new tab) Full text (opens in new tab) Alzheimer’s disease Er-mitochondria crosstalk N,N-Dimethyltryptamine Cognitive impairment +4

The flattening of spacetime hierarchy of the N,N-dimethyltryptamine brain state is characterized by harmonic decomposition of spacetime (HADES) framework.

National Science Review May 1, 2024 Jakub Vohryzek, Joana Cabral, Christopher Timmermann et al. 13 citations

The human brain is a complex system, whose activity exhibits flexible and continuous reorganization across space and time. The decomposition of whole-brain recordings into harmonic modes has revealed a repertoire of gradient-like activity patterns associated with distinct brain functions. However, the way these activity patterns are expressed over time with their changes in various brain states...

DOI: 10.1093/nsr/nwae124 (opens in new tab) Full text (opens in new tab) DMT Harmonic modes Spatio-temporal brain dynamics Psychedelics hallucinogens +9

The Potential Use of Dimethyltryptamine against Ischemia-reperfusion Injury of the Brain

Journal of Neuroscience and Neurological Disorders April 19, 2024 Attila Kovács, Anna Mathe, Ede Frecska 2 citations

Ischemia-Reperfusion Injury (IRI) is the outcome of two intertwined pathological processes resulting from the shortage of blood flow to tissues and the subsequent restoration of circulation to a previously ischemic area. IRI (sometimes just one side of the dyad) remains one of the most challenging problems in several branches of emergency medicine. Mitochondrial and endoplasmic reticulum...

The potential of 5‐methoxy‐N,N‐dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action

Addiction Biology April 1, 2024 Stephan Tap 12 citations

Abstract Alcohol use disorder (AUD) remains one of the most prevalent psychiatric disorders worldwide with high economic costs. Current treatment options show modest efficacy and relapse rates are high. Furthermore, there are increases in the treatment gap and few new medications have been approved in the past 20 years. Recently, psychedelic‐assisted therapy with psilocybin and lysergic acid...

Experiências anômalas com ayahuasca e DMT: uma leitura psicossocial

March 22, 2024 Ricardo Assarice Dos Santos

dos quais 100% alegaram vivenciar ao menos algum tipo de experincia anmala.Os resultados revelaram uma diversidade de experincias, destacando a prevalncia de Experincias Msticas (95%), Experincias Visionrias (93,5%) e Experincias Fora do Corpo (86,8%).A pesquisa tambm identificou considervel prevalncia de experincias ufolgicas (42,9%), correlacionadas com fatores psicossociais como crenas